In July 2021, FDA approved the first interchangeable biosimilar insulin product (Semglee–Viatris/Biocon Biologics, insulin glargineyfgn), which can be substituted for its reference product (Lantus–Sanofi Aventis, insulin glargine) at the pharmacy level, depending on state pharmacy laws.

From hypertension guidelines to calculating kidney function, race is a key component of how pharmacists are taught to identify which medication a patient should be taking and whether a medication is needed.

nterventions led by pharmacists and community health workers are most likely to help patients with hypertension achieve disease control, according to research published July 19, 2024, in the American Heart Association’s (AHA’s) journal Circulation: Cardiovascular Quality and OutcomesCirculation: Cardiovascular Quality and Outcomes.